Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Stopped Study was never submitted to the IRB \& never opened. PI is leaving institution.

Conditions

• Biliary Tract Cancer

Interventions

• DRUG: Irinotecan & Capecitabine

Sponsor

New Mexico Cancer Research Alliance